Literature DB >> 27647909

Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.

Hong Zheng1, Wei Dai1, Arthur Kwok Leung Cheung1, Josephine Mun Yee Ko1, Rebecca Kan1, Bonnie Wing Yan Wong1, Merrin Man Long Leong1, Mingdan Deng1, Tommy Chin Tung Kwok1, Jimmy Yu-Wai Chan2, Dora Lai-Wan Kwong3, Anne Wing-Mui Lee3, Wai Tong Ng4, Roger Kai Cheong Ngan5, Chun Chung Yau6, Stewart Tung7, Victor Ho-Fun Lee3, Ka-On Lam3, Chung Kong Kwan5, Wing Sum Li5, Stephen Yau8, Kwok-Wah Chan9, Maria Li Lung10.   

Abstract

Nasopharyngeal carcinoma (NPC) is an epithelial malignancy with a unique geographical distribution. The genomic abnormalities leading to NPC pathogenesis remain unclear. In total, 135 NPC tumors were examined to characterize the mutational landscape using whole-exome sequencing and targeted resequencing. An APOBEC cytidine deaminase mutagenesis signature was revealed in the somatic mutations. Noticeably, multiple loss-of-function mutations were identified in several NF-κB signaling negative regulators NFKBIA, CYLD, and TNFAIP3 Functional studies confirmed that inhibition of NFKBIA had a significant impact on NF-κB activity and NPC cell growth. The identified loss-of-function mutations in NFKBIA leading to protein truncation contributed to the altered NF-κB activity, which is critical for NPC tumorigenesis. In addition, somatic mutations were found in several cancer-relevant pathways, including cell cycle-phase transition, cell death, EBV infection, and viral carcinogenesis. These data provide an enhanced road map for understanding the molecular basis underlying NPC.

Entities:  

Keywords:  APOBEC-mediated signature; NF-κB signaling; nasopharyngeal carcinoma; somatic mutation landscape; whole-exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27647909      PMCID: PMC5056105          DOI: 10.1073/pnas.1607606113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

2.  Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.

Authors:  N Sasaki; T Morisaki; K Hashizume; T Yao; M Tsuneyoshi; H Noshiro; K Nakamura; T Yamanaka; A Uchiyama; M Tanaka; M Katano
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Structure of an IkappaBalpha/NF-kappaB complex.

Authors:  M D Jacobs; S C Harrison
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

Review 4.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

Review 5.  Nasopharyngeal Cancer: Molecular Landscape.

Authors:  Jeff P Bruce; Kenneth Yip; Scott V Bratman; Emma Ito; Fei-Fei Liu
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

6.  Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.

Authors:  Mark M Sasaki; Andrew D Skol; Riyue Bao; Lindsay V Rhodes; Rachelle Chambers; Everett E Vokes; Ezra E W Cohen; Kenan Onel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-26       Impact factor: 4.254

7.  Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.

Authors:  Wei Dai; Hong Zheng; Arthur Kwok Leung Cheung; Clara Sze-man Tang; Josephine Mun Yee Ko; Bonnie Wing Yan Wong; Merrin Man Long Leong; Pak Chung Sham; Florence Cheung; Dora Lai-Wan Kwong; Roger Kai Cheong Ngan; Wai Tong Ng; Chun Chung Yau; Jianji Pan; Xun Peng; Stewart Tung; Zengfeng Zhang; Mingfang Ji; Alan Kwok-Shing Chiang; Anne Wing-Mui Lee; Victor Ho-Fun Lee; Ka-On Lam; Kwok Hung Au; Hoi Ching Cheng; Harry Ho-Yin Yiu; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

8.  Absence of p53 gene mutations in primary nasopharyngeal carcinomas.

Authors:  C H Spruck; Y C Tsai; D P Huang; A S Yang; W M Rideout; M Gonzalez-Zulueta; P Choi; K W Lo; M C Yu; P A Jones
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

9.  Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.

Authors:  Wei Dai; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Yue Cheng; Hong Zheng; Roger Kai Cheong Ngan; Wai Tong Ng; Anne Wing Mui Lee; Chun Chung Yau; Victor Ho Fu Lee; Maria Li Lung
Journal:  Cancer Med       Date:  2015-04-29       Impact factor: 4.452

Review 10.  APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.

Authors:  Charles Swanton; Nicholas McGranahan; Gabriel J Starrett; Reuben S Harris
Journal:  Cancer Discov       Date:  2015-06-19       Impact factor: 39.397

View more
  60 in total

1.  Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

Authors:  Chong Wang; Sizun Jiang; Liangru Ke; Luyao Zhang; Difei Li; Jun Liang; Yohei Narita; Isabella Hou; Chen-Hao Chen; Liangwei Wang; Qian Zhong; Yihong Ling; Xing Lv; Yanqun Xiang; Xiang Guo; Mingxiang Teng; Sai-Wah Tsao; Benjamin E Gewurz; Mu-Sheng Zeng; Bo Zhao
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

Review 2.  The molecular march of primary and recurrent nasopharyngeal carcinoma.

Authors:  Nicholas J Campion; Munira Ally; Bernhard J Jank; Jahangir Ahmed; Ghassan Alusi
Journal:  Oncogene       Date:  2021-01-21       Impact factor: 9.867

Review 3.  A20: A multifunctional tool for regulating immunity and preventing disease.

Authors:  Barbara A Malynn; Averil Ma
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

4.  Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.

Authors:  Jun Zhang; Lin Jia; Weitao Lin; Yim Ling Yip; Kwok Wai Lo; Victoria Ming Yi Lau; Dandan Zhu; Chi Man Tsang; Yuan Zhou; Wen Deng; Hong Lok Lung; Maria Li Lung; Lai Man Cheung; Sai Wah Tsao
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.

Authors:  Kartik Viswanathan; Peter M Sadow
Journal:  Hum Pathol       Date:  2021-08-18       Impact factor: 3.466

Review 6.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

Review 7.  Epstein-Barr virus infection and nasopharyngeal carcinoma.

Authors:  Sai Wah Tsao; Chi Man Tsang; Kwok Wai Lo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

8.  Landscape of Microsatellite Instability Across 39 Cancer Types.

Authors:  Russell Bonneville; Melanie A Krook; Esko A Kautto; Jharna Miya; Michele R Wing; Hui-Zi Chen; Julie W Reeser; Lianbo Yu; Sameek Roychowdhury
Journal:  JCO Precis Oncol       Date:  2017-10-03

9.  Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Authors:  Ren-Bo Ding; Ping Chen; Barani Kumar Rajendran; Xueying Lyu; Haitao Wang; Jiaolin Bao; Jianming Zeng; Wenhui Hao; Heng Sun; Ada Hang-Heng Wong; Monica Vishnu Valecha; Eun Ju Yang; Sek Man Su; Tak Kan Choi; Shuiming Liu; Kin Iong Chan; Ling-Lin Yang; Jingbo Wu; Kai Miao; Qiang Chen; Joong Sup Shim; Xiaoling Xu; Chu-Xia Deng
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

Review 10.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.